Aberdeen Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,233	Closed	-$2.25M	–	922
2024 Q2	$2.25M	Sell	8,233 -430	-5%	-$125K	﹤0.01%	740
2024 Q1	$3M	Sell	8,663 -129	-1%	-$42.4K	0.01%	740
2023 Q4	$2.84M	Buy	8,792 +3,588	+69%	+$1.12M	0.01%	748
2023 Q3	$1.87M	Sell	5,204 -261	-5%	-$101K	﹤0.01%	703
2023 Q2	$2.07M	Sell	5,465 -234	-4%	-$95.2K	﹤0.01%	718
2023 Q1	$2.73M	Sell	5,699 -2,566	-31%	-$1.2M	0.01%	685
2022 Q4	$3.48M	Buy	8,265 +3,085	+60%	+$1.25M	0.01%	614
2022 Q3	$2.16M	Buy	5,180 +31	+0.6%	+$15.5K	0.01%	697
2022 Q2	$2.56M	Sell	5,149 -186	-3%	-$96.9K	0.01%	681
2022 Q1	$3.06M	Sell	5,335 -995	-16%	-$600K	0.01%	676
2021 Q4	$4.78M	Sell	6,330 -744	-11%	-$557K	0.01%	645
2021 Q3	$5.3M	Sell	7,074 -2,293	-24%	-$1.72M	0.01%	643
2021 Q2	$6.04M	Sell	9,367 -180	-2%	-$110K	0.01%	606
2021 Q1	$5.45M	Buy	9,547 +325	+4%	+$192K	0.01%	629
2020 Q4	$5.38M	Buy	9,222 +2,578	+39%	+$1.47M	0.01%	586
2020 Q3	$3.42M	Buy	6,644 +524	+9%	+$265K	0.01%	629
2020 Q2	$2.76M	Buy	6,120 +4,809	+367%	+$2.12M	0.01%	656
2020 Q1	$460K	Buy	1,311 +171	+15%	+$62.9K	﹤0.01%	843
2019 Q4	$422K	Buy	+1,140	New	+$402K	﹤0.01%	895